Order or notice
Maharashtra FDA's ayurvedic manufacturers drive: 434 units, 10 licences cancelled (Aug 2026)
Last checked 10 October 2026
By Aug 2026 Maharashtra FDA had inspected 434 ayurvedic manufacturing units, issued 135 show-cause notices and permanently cancelled 10 licences for failures against Schedule T, the good manufacturing practice requirements.
- Classification
- Regulatory notice or advisory
- Decided by
- Maharashtra Food and Drug Administration
- Reference
- Reported in Open magazine, Aug 2026; the list of units and orders is not published
- Latest action
- 12 August 2026
- Last checked
- 10 October 2026
Photo: Ayurvedic herbs 02.jpg by Vis M (CC BY-SA 4.0). All photo credits.
Maharashtra FDA: not of standard quality (NSQ) alerts table
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Units inspected
- 434
- Show-cause notices
- 135
- Licences cancelled
- 10, permanently, for Schedule T (good manufacturing practice) failures
- Named firm
- Inducare Pharma, Jejuri: licence cancelled on 8 Aug 2026 (separate record)
In 2026 Maharashtra FDA turned to ayurvedic manufacturers. Open magazine reported in Aug 2026 that the regulator had inspected 434 ayurvedic units, issued 135 show-cause notices and permanently cancelled 10 licences for failures against Schedule T of the Drugs and Cosmetics Rules, which sets good manufacturing practice (GMP) requirements.
The report gives counts but no list of units. The one firm we can name from other sources is Inducare Pharma of Jejuri, whose licence was cancelled on 8 Aug 2026 after fungus, insects and larvae were reported in six products.
Inspection counts and notices are not findings against any brand, and the names of the other cancellations are not in our sources.
What this means for you
A notice is a first step
A show-cause notice asks a firm to explain. It is not a finding, a suspension or a ban.
Firms are not named
The report gives counts, not names, other than the Inducare case. We do not attribute the cancellations to any brand.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Which companies lost their licences?
The report we read gives the number, 10, and not the names. The one firm named in our sources is Inducare Pharma, whose licence was cancelled on 8 Aug 2026.
Official sources and primary records
- News
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026